Menzel et al., 1996 - Google Patents
Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabineMenzel et al., 1996
View HTML- Document ID
- 9199608687550216901
- Author
- Menzel T
- Rahman Z
- Calleja E
- White K
- Wilson E
- Wieder R
- Gabrilove J
- Publication year
External Links
Snippet
Chronic lymphocytic leukemia (CLL) is characterized by delayed senescence and slow accumulation of monoclonal, small lymphocytes. Basic fibroblast growth factor (bFGF) is a pleiotropic cytokine that plays a role in hematopoiesis and apoptosis. Elevated bFGF levels …
- 108090000379 Fibroblast Growth Factor 2 0 title abstract description 135
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Menzel et al. | Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine | |
| Rajkumar et al. | Prognostic factors in multiple myeloma | |
| Pellat-Deceunynck et al. | Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells | |
| Ashman et al. | Expression of the YB5. B8 antigen (c-kit proto-oncogene product) in normal human bone marrow | |
| Till et al. | Hemopoietic stem cell differentiation | |
| Ross et al. | Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number | |
| Herault et al. | A rapid single‐laser flow cytometric method for discrimination of early apoptotic cells in a heterogenous cell population | |
| Sutherland et al. | Characterization of a hierarchy in human acute myeloid leukemia progenitor cells | |
| Pollice et al. | Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins | |
| Castro-Malaspina et al. | Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders | |
| Mehrotra et al. | Cytogenetically aberrant cells in the stem cell compartment (CD34+ lin-) in acute myeloid leukemia | |
| Darzynkiewicz et al. | Different sensitivity of chromatin to acid denaturation in quiescent and cycling cells as revealed by flow cytometry. | |
| Xue et al. | Characterisation of fibroblast-like cells in pannus lesions of patients with rheumatoid arthritis sharing properties of fibroblasts and chondrocytes | |
| Chiao et al. | Changes of cellular markers during differentiation of HL-60 promyelocytes to macrophages as induced by T lymphocyte conditioned medium | |
| Thurau et al. | Identification of eosinophils by flow cytometry | |
| Spiteri et al. | Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage | |
| WO2003004995A2 (en) | High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation | |
| AU2002335610A1 (en) | High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation | |
| Wang et al. | Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4-and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells | |
| Giordano et al. | Proliferating cell nuclear antigen (PCNA)/cyclin expression during the cell cycle in normal and leukemic cells | |
| Doyle et al. | An adherent subline of a unique small-cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule. | |
| US5891654A (en) | Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression | |
| Czerniak et al. | Modification of Ha-ras oncogene p21 expression and cell cycle progression in the human colonic cancer cell line HT-29 | |
| Popma et al. | Immune monitoring in xenotransplantation: the multiparameter flow cytometric mixed lymphocyte culture assay | |
| Delwel et al. | Fucose binding lectin for characterizing acute myeloid leukemia progenitor cells |